Empagliflozin-Induced Acute Pancreatitis and Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus. American Journal of Chemistry and Pharmacy, [S. l.], v. 1, n. 2, p. 1–4, 2022. DOI: 10.54536/ajcp.v1i2.747. Disponível em: https://e-pallipublishers.com/index.php/ajcp/article/view/747. Acesso em: 28 jul. 2026.